This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ljungman P, Brand R, Hoek J, de la Camara R, Cordonnier C, Einsele H et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis 2014; 59: 473–481.
Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ et al. The Impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder. Am J Transplant 2015; 15: 2665–2673.
Sorror M . Impacts of pre transplant comorbidities on allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15: 149–153.
Gratwohl A . The EBMT risk score. Bone Marrow Transplant 2012; 47: 749–756.
Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT . Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dose regimens. J Clin Oncol 1991; 9: 1215–1223.
Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 1–11.
Coghlan JG, Handler CE, Kottaridis PD . Cardiac assessment of patients for hematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2007; 20: 247–263.
Miniati I, Conforti ML, Bernardo P, Tyndall A, Gensini GF, Matucci-Cerinic M . Hematopoietic stem cell transplantation in autoimmune diseases algorithm for cardiovascular assessment. Herz 2007; 32: 43–50.
Coghlan JG, Handler CE, Kottaridis PD . Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2007; 20: 247–263.
Kovács Á, Papp Z, Nagy L . Causes and pathophysiology of heart failure with preserved ejection fraction. Heart Fail Clin 2014; 10: 389–398.
Hurley P, Konety S, Cao Q, Weisdorf D, Blaes A . Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done? Biol Blood Marrow Transplant 2015; 21: 300–304.
Kalay N, Basar E, Ozdogru ErO, Cetinkaya I, Dogan A et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 2006; 48: 2258–2262.
Blaes AH, Gaillard P, Peterson BA, Yee D, Virnig D . Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy. Breast Cancer Res Treat 2010; 122: 585–590.
Cardinale D, Bacchiani G, Beggiato M, Colombo A, Cipolla CM . Strategies to prevent and treat cardiovascular risk in cancer patients. Semin Oncol 2013; 40: 186–198.
Bosch X, Rovira M, Sitges M, Domènech A, Ortiz-Pérez JT, de Caralt TM et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol 2013; 61: 2355–2362.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sarmiento, M., Parody, R., Márquez-Malaver, F. et al. Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation. Bone Marrow Transplant 51, 863–865 (2016). https://doi.org/10.1038/bmt.2016.8
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.8
This article is cited by
-
Pretransplant plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide are more useful prognostic markers of overall survival after allogeneic hematopoietic cell transplantation than echocardiography
Bone Marrow Transplantation (2021)
-
Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
Bone Marrow Transplantation (2021)